文献速递精神分裂症与精神病性障碍

泛素-蛋白酶体系统与精神分裂症

The ubiquitin proteasome system and schizophrenia.
PubMed 文献 · Lancet Psychiatry · 2020-02-12

本文综述泛素-蛋白酶体系统在神经发育与脑结构功能维持中的核心调控作用,及其通过影响支架蛋白、突触前与突触后蛋白的定位、相互作用和周转来调节神经发生、突触发生与神经传递。文中汇总了在精神分裂症中被报道失调的泛素-蛋白酶体系统组分,并讨论这些组分的特定分子改变可能部分解释该精神障碍的复杂病因。

要点

  • 泛素-蛋白酶体系统调控神经发生、突触发生与神经传递。
  • 该系统信号可不依赖蛋白降解而转导神经元表观遗传改变。
  • 精神分裂症中报道存在泛素-蛋白酶体系统组分失调。

核心结论

  • 泛素-蛋白酶体系统功能异常与精神分裂症等神经发育障碍存在关联,其组分失调或部分解释该病复杂病因。

研究设计与样本

  • 综述类文章,检索并汇总文献中报道在精神分裂症中失调的泛素-蛋白酶体系统组分。

主要发现

  • 泛素-蛋白酶体系统通过决定支架、突触前和突触后蛋白的定位、相互作用与周转,影响神经发生、突触发生和神经传递。
  • 该系统信号可独立于蛋白降解转导神经元表观遗传改变。
  • 该系统组分及底物功能障碍已被联系到多种脑部疾病。
  • 泛素-蛋白酶体系统功能异常与神经退行性疾病的关联已知较久,与精神分裂症等神经发育障碍的关联近期才出现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The ubiquitin-proteasome system is a master regulator of neural development and the maintenance of brain structure and function. It influences neurogenesis, synaptogenesis, and neurotransmission by determining the localisation, interaction, and turnover of scaffolding, presynaptic, and postsynaptic proteins. Moreover, ubiquitin-proteasome system signalling transduces epigenetic changes in neurons independently of protein degradation and, as such, dysfunction of components and substrates of this system has been linked to a broad range of brain conditions. Although links between ubiquitin-proteasome system dysfunction and neurodegenerative disorders have been known for some time, only recently have similar links emerged for neurodevelopmental disorders, such as schizophrenia. Here, we review the components of the ubiquitin-proteasome system that are reported to be dysregulated in schizophrenia, and discuss specific molecular changes to these components that might, in part, explain the complex causes of this mental disorder.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Luza S, Opazo CM, Bousman CA, et al. The ubiquitin proteasome system and schizophrenia. Lancet Psychiatry. 2020. PMID: 32061320. doi:10.1016/S2215-0366(19)30520-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。